2026 Q1 Portfolio Activity
In 2026 Q1, Seven Fleet Capital Management LP maintained a portfolio of 130 distinct positions. The most significant new addition was CENTURY THERAPEUTICS INC, now representing 2.11% of the total fund value. They heavily accumulated shares in TANGO THERAPEUTICS INC, increasing the position by 5492.4%. The fund also reduced its exposure to CG ONCOLOGY INC by 95.0%.
Position History
hover any row below to update
Loading…
Total Positions
130
Quarter
2026 Q1
Top Holding
CGON (30.9%)
Top 10 Concentration
51.8%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-50 of 130
Seven Fleet Capital Management LP Full Holdings List — 2026 Q1
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
CGON
CG ONCOLOGY INC
|
Healthcare | 30.92% | 47.85% |
#1
Prev: #1
|
6.5 |
—
|
-75,758 | -5.0% |
P
S
|
1,439,393 | $97,418,118 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
TNGX
TANGO THERAPEUT...
|
Healthcare | 3.33% | 1.45% |
#2
8
Prev: #10
|
5.8 |
—
|
286,840 | 133.3% |
P
S
|
502,012 | $10,502,091 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
RVMD
REVOLUTION MEDI...
|
Healthcare | 2.49% | 3.99% |
#3
Prev: #3
|
4.5 |
—
|
14,992 | 22.8% |
P
S
|
80,792 | $7,857,022 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
TYRA
TYRA BIOSCIENCE...
|
Healthcare | 2.38% | 1.59% |
#4
4
Prev: #8
|
4.5 |
—
|
116,125 | 146.0% |
P
S
|
195,685 | $7,494,736 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
LQDA
LIQUIDIA CORPOR...
|
Healthcare | 2.25% | 2.39% |
#5
1
Prev: #4
|
4.4 |
—
|
96,609 | 105.9% |
P
S
|
187,876 | $7,090,440 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
AGIO
AGIOS PHARMACEU...
|
Healthcare | 2.25% | 0.66% |
#6
23
Prev: #29
|
3.9 |
—
|
177,809 | 560.2% |
P
S
|
209,547 | $7,088,975 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
IPSC
CENTURY THERAPE...
|
Healthcare | 2.11% | — |
#7
Prev: #—
|
4.3 |
—
|
2,947,826 | — |
NEW
|
2,947,826 | $6,662,087 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ELVN
ENLIVEN THERAPE...
|
Healthcare | 2.04% | 0.14% |
#8
54
Prev: #62
|
3.8 |
—
|
152,342 | 1303.4% |
P
S
|
164,030 | $6,429,976 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
PCVX
VAXCYTE INC
|
Healthcare | 2.00% | 0.89% |
#9
10
Prev: #19
|
3.8 |
—
|
83,085 | 327.6% |
P
S
|
108,450 | $6,302,029 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
N/A
TANGO THERAPEUT...
|
|
Unknown | 2.00% | — |
#10
Prev: #—
|
4.3 |
—
|
300,648 | — |
NEW
|
300,648 | $6,289,556 | — | 13F Filing | 2026-03-31 | 2026-05-15 | ||
|
COGT
COGENT BIOSCIEN...
|
Healthcare | 1.82% | 1.46% |
#11
2
Prev: #9
|
3.7 |
—
|
95,374 | 176.5% |
P
S
|
149,399 | $5,750,368 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
AVTX
AVALO THERAPEUT...
|
Healthcare | 1.71% | 0.87% |
#12
8
Prev: #20
|
3.7 |
—
|
296,721 | 468.4% |
P
S
|
360,064 | $5,375,756 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
NERV
MINERVA NEUROSC...
|
Healthcare | 1.70% | — |
#13
Prev: #—
|
4.2 |
—
|
889,254 | — |
NEW
|
889,254 | $5,357,755 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
PHVS
PHARVARIS N V
|
Healthcare | 1.55% | 1.17% |
#15
3
Prev: #12
|
3.6 |
—
|
117,389 | 212.1% |
P
S
|
172,731 | $4,879,651 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ABVX
ABIVAX SA
|
Healthcare | 1.52% | 0.00% |
#16
68
Prev: #84
|
3.6 |
—
|
43,040 | 358666.7% |
P
S
|
43,052 | $4,793,840 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
DNTH
DIANTHUS THERAP...
|
Healthcare | 1.45% | 0.46% |
#17
24
Prev: #41
|
3.6 |
—
|
39,607 | 270.3% |
P
S
|
54,258 | $4,553,331 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
CYTK
CYTOKINETICS IN...
|
Healthcare | 1.28% | 0.50% |
#19
18
Prev: #37
|
3.5 |
—
|
50,934 | 492.8% |
P
S
|
61,269 | $4,038,240 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
SLNO
SOLENO THERAPEU...
|
Healthcare | 1.23% | 4.58% |
#20
18
Prev: #2
|
1.0 |
—
|
-14,309 | -11.0% |
P
S
|
115,770 | $3,875,980 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ERAS
ERASCA INC
|
Healthcare | 1.14% | — |
#22
Prev: #—
|
4.0 |
—
|
222,468 | — |
NEW
|
222,468 | $3,599,532 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ROIV
ROIVANT SCIENCE...
|
Healthcare | 1.13% | — |
#23
Prev: #—
|
4.0 |
—
|
128,168 | — |
NEW
|
128,168 | $3,550,254 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
CTMX
CYTOMX THERAPEU...
|
Healthcare | 1.07% | 0.16% |
#24
36
Prev: #60
|
3.4 |
—
|
665,102 | 1360.2% |
P
S
|
714,000 | $3,355,800 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
EPRX
EUPRAXIA PHARMA...
|
Healthcare | 1.00% | — |
#26
Prev: #—
|
3.9 |
—
|
433,515 | — |
NEW
|
433,515 | $3,138,649 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
IDYA
IDEAYA BIOSCIEN...
|
Healthcare | 0.91% | — |
#27
Prev: #—
|
3.9 |
—
|
86,283 | — |
NEW
|
86,283 | $2,874,950 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
TSHA
TAYSHA GENE THE...
|
Healthcare | 0.89% | 0.70% |
#28
2
Prev: #26
|
3.4 |
—
|
458,485 | 274.2% |
P
S
|
625,708 | $2,796,915 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ASND
ASCENDIS PHARMA...
|
Healthcare | 0.88% | 0.92% |
#29
12
Prev: #17
|
3.4 |
—
|
6,509 | 114.8% |
P
S
|
12,179 | $2,785,703 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
CMPX
COMPASS THERAPE...
|
Healthcare | 0.87% | 2.32% |
#30
25
Prev: #5
|
0.8 |
—
|
-51,775 | -9.1% |
P
S
|
516,972 | $2,734,782 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
GLTO
DAMORA THERAPEU...
|
Healthcare | 0.83% | — |
#31
Prev: #—
|
3.8 |
—
|
101,248 | — |
NEW
|
101,248 | $2,622,323 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
KALV
KALVISTA PHARMA...
|
Healthcare | 0.82% | 0.59% |
#32
Prev: #32
|
3.3 |
—
|
80,075 | 165.4% |
P
S
|
128,487 | $2,586,443 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
RLAY
RELAY THERAPEUT...
|
Healthcare | 0.81% | 0.47% |
#33
7
Prev: #40
|
3.3 |
—
|
184,738 | 253.1% |
P
S
|
257,738 | $2,564,493 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
AXSM
AXSOME THERAPEU...
|
Healthcare | 0.75% | 1.80% |
#34
27
Prev: #7
|
2.3 |
—
|
1,100 | 8.5% |
P
S
|
14,055 | $2,375,576 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
DFTX
DEFINIUM THERAP...
|
Healthcare | 0.60% | — |
#38
Prev: #—
|
3.7 |
—
|
99,887 | — |
NEW
|
99,887 | $1,887,864 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
MLYS
MINERALYS THERA...
|
Healthcare | 0.60% | 0.42% |
#39
4
Prev: #43
|
3.2 |
—
|
54,328 | 356.4% |
P
S
|
69,571 | $1,884,678 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
N/A
SOLENO THERAPEU...
|
|
Unknown | 0.57% | — |
#40
Prev: #—
|
3.7 |
—
|
54,000 | — |
NEW
|
54,000 | $1,807,920 | — | 13F Filing | 2026-03-31 | 2026-05-15 | ||
|
MDGL
MADRIGAL PHARMA...
|
Healthcare | 0.56% | 0.82% |
#41
19
Prev: #22
|
3.2 |
—
|
1,533 | 82.4% |
P
S
|
3,393 | $1,776,134 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
LONA
LEONABIO INC
|
Healthcare | 0.54% | 0.74% |
#43
18
Prev: #25
|
2.7 |
—
|
36,725 | 28.7% |
P
S
|
164,676 | $1,692,869 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
SVRA
SAVARA INC
|
Healthcare | 0.51% | 0.29% |
#44
6
Prev: #50
|
3.2 |
—
|
232,926 | 371.1% |
P
S
|
295,688 | $1,614,456 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
CATX
PERSPECTIVE THE...
|
Healthcare | 0.50% | — |
#45
Prev: #—
|
3.7 |
—
|
379,082 | — |
NEW
|
379,082 | $1,580,772 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ASMB
ASSEMBLY BIOSCI...
|
Healthcare | 0.49% | 0.11% |
#46
18
Prev: #64
|
3.2 |
—
|
51,832 | 1201.2% |
P
S
|
56,147 | $1,558,080 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
SABS
SAB BIOTHERAPEU...
|
Healthcare | 0.49% | — |
#47
Prev: #—
|
3.7 |
—
|
400,000 | — |
NEW
|
400,000 | $1,532,000 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ZLAB
ZAI LAB LTD
|
Healthcare | 0.46% | — |
#49
Prev: #—
|
3.7 |
—
|
77,858 | — |
NEW
|
77,858 | $1,464,509 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
TARS
TARSUS PHARMACE...
|
Healthcare | 0.44% | 0.28% |
#50
1
Prev: #51
|
3.2 |
—
|
15,300 | 340.0% |
P
S
|
19,800 | $1,388,970 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
CRVS
CORVUS PHARMACE...
|
Healthcare | 0.38% | — |
#51
Prev: #—
|
3.7 |
—
|
82,890 | — |
NEW
|
82,890 | $1,212,681 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
AVBP
ARRIVENT BIOPHA...
|
Healthcare | 0.37% | — |
#53
Prev: #—
|
3.6 |
—
|
50,252 | — |
NEW
|
50,252 | $1,159,314 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
LRMR
LARIMAR THERAPE...
|
Healthcare | 0.37% | — |
#54
Prev: #—
|
3.6 |
—
|
256,585 | — |
NEW
|
256,585 | $1,154,633 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
KRYS
KRYSTAL BIOTECH...
|
Healthcare | 0.35% | 0.75% |
#55
31
Prev: #24
|
2.1 |
—
|
316 | 7.9% |
P
S
|
4,316 | $1,114,909 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
IVA
INVENTIVA SA
|
Healthcare | 0.35% | — |
#56
Prev: #—
|
3.6 |
—
|
200,141 | — |
NEW
|
200,141 | $1,110,783 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
LPCN
LIPOCINE INC NE...
|
Healthcare | 0.32% | — |
#57
Prev: #—
|
3.6 |
—
|
124,942 | — |
NEW
|
124,942 | $998,287 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
SYRE
SPYRE THERAPEUT...
|
Healthcare | 0.32% | — |
#58
Prev: #—
|
3.6 |
—
|
19,690 | — |
NEW
|
19,690 | $993,164 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
BCRX
BIOCRYST PHARMA...
|
Healthcare | 0.31% | — |
#59
Prev: #—
|
3.6 |
—
|
102,493 | — |
NEW
|
102,493 | $975,733 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
XNCR
XENCOR INC
|
Healthcare | 0.31% | 1.28% |
#60
49
Prev: #11
|
0.1 |
—
|
-29,554 | -27.0% |
P
S
|
80,000 | $964,800 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 |
Showing 1-50 of 130 holdings